223 related articles for article (PubMed ID: 36872215)
1. [Hereditary angioedema and its new treatments: An update].
Launay D; Bouillet L; Boccon-Gibod I; Trumbic B; Gobert D; ; Fain O
Rev Med Interne; 2023 Jul; 44(7):344-353. PubMed ID: 36872215
[TBL] [Abstract][Full Text] [Related]
2. Current management options for hereditary angioedema.
Bork K
Curr Allergy Asthma Rep; 2012 Aug; 12(4):273-80. PubMed ID: 22729959
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Hereditary Angioedema.
Caballero T
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):1-16. PubMed ID: 33602658
[TBL] [Abstract][Full Text] [Related]
4. [Hereditary angioedema due to C1-esterase inhibitor deficiency : novel approaches].
Stehlin F; Ribi C
Rev Med Suisse; 2020 Apr; 16(689):675-678. PubMed ID: 32270933
[TBL] [Abstract][Full Text] [Related]
5. [Acquired angioedema due to C1-inhibitor deficiency: CREAK recommendations for diagnosis and treatment].
Gobert D; Bouillet L; Armengol G; Coppo P; Defendi F; Du-Thanh A; Hardy G; Javaud N; Jeandel PY; Launay D; Panayotopoulos V; Pelletier F; Boccon-Gibod I; Fain O
Rev Med Interne; 2020 Dec; 41(12):838-842. PubMed ID: 32753245
[TBL] [Abstract][Full Text] [Related]
6. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
Jacobs J; Neeno T
Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
[TBL] [Abstract][Full Text] [Related]
7. A review of berotralstat for the treatment of hereditary angioedema.
Farkas H; Balla Z
Expert Rev Clin Immunol; 2023 Feb; 19(2):145-153. PubMed ID: 36408587
[TBL] [Abstract][Full Text] [Related]
8. Acquired and hereditary forms of recurrent angioedema: Update of treatment.
Bork K
Allergol Select; 2018; 2(1):121-131. PubMed ID: 31826031
[TBL] [Abstract][Full Text] [Related]
9. Hereditary angioedema: how to approach it at the emergency department?
Serpa FS; Mansour E; Aun MV; Giavina-Bianchi P; Chong Neto HJ; Arruda LK; Campos RA; Motta AA; Toledo E; Grumach AS; Valle SOR
Einstein (Sao Paulo); 2021; 19():eRW5498. PubMed ID: 33852678
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.
Zanichelli A; Mansi M; Periti G; Cicardi M
Expert Rev Clin Immunol; 2013 May; 9(5):477-88. PubMed ID: 23634741
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hereditary angioedema-single or multiple pathways to the rescue.
Valerieva A; Longhurst HJ
Front Allergy; 2022; 3():952233. PubMed ID: 36172291
[TBL] [Abstract][Full Text] [Related]
12. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
[TBL] [Abstract][Full Text] [Related]
13. Nanofiltrated C1-esterase-inhibitor in the prophylactic treatment of bradykinin-mediated angioedema.
Greve J; Hahn J; Nordmann M; Schuler PJ; Bas M; Hoffmann TK; Hajdu Z; Buchberger M; Strassen U
Transfusion; 2016 May; 56(5):1022-9. PubMed ID: 26756974
[TBL] [Abstract][Full Text] [Related]
14. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for the treatment of hereditary angioedema due to C1-inhibitor deficiency.
Zanichelli A; Montinaro V; Triggiani M; Arcoleo F; Visigalli D; Cancian M
Expert Opin Emerg Drugs; 2022 Jun; 27(2):103-110. PubMed ID: 35876094
[TBL] [Abstract][Full Text] [Related]
16. Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries.
Guo Y; Zhang H; Lai H; Wang H; Chong-Neto HJ; Valle SOR; Zhu R
Orphanet J Rare Dis; 2022 Nov; 17(1):399. PubMed ID: 36324138
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of long term treatments of type I hereditary angioedema in a Turkish family.
Akoglu G; Kesim B; Yildiz G; Metin A
An Bras Dermatol; 2017; 92(5):655-660. PubMed ID: 29166502
[TBL] [Abstract][Full Text] [Related]
18. An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension.
Riedl MA; Bernstein JA; Craig T; Banerji A; Magerl M; Cicardi M; Longhurst HJ; Shennak MM; Yang WH; Schranz J; Baptista J; Busse PJ
Clin Transl Allergy; 2017; 7():36. PubMed ID: 29043014
[TBL] [Abstract][Full Text] [Related]
19. [Management of bradykinin-mediated angioedema].
Floccard B; Crozon J; Rimmelé T; Vulliez A; Coppere B; Chamouard V; Boccon-Gibod I; Bouillet L; Allaouchiche B
Ann Fr Anesth Reanim; 2011; 30(7-8):578-88. PubMed ID: 21454034
[TBL] [Abstract][Full Text] [Related]
20. Managing Chronic Urticaria and Recurrent Angioedema Differently with Advancing Age.
Longhurst HJ; Gonçalo M; Godse K; Ensina LF
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2186-2194. PubMed ID: 33819638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
